Solid quarterly results from $JPM, $GS. Guidance from JPMorgan not great.JPMorgan Chase (NYSE:$JPM ): Q2 GAAP EPS of $2.82 beats by $0.33. Revenue of $29.57B (+4.2% Y/Y) beats by $1.05B....GS:Q2 GAAP EPS of $5.81 beats by $0.72. Revenue of $9.46B (-1.9% Y/Y) beats by $580M.In the drug stock space, $TEVA took a turn lower. Buy the dip...eventually. $5 approaching. $TEVA, Teva Pharmaceutical Industries Limited / H1 Time to buy $JNJ? Stock is getting to value territory: $JNJ, Johnson & Johnson / H1 The baby powder litigation risks are priced in the stock.In the M&A space, Symantec $SYMC mgt. thinks the stock is worth $28. LOL. Consider buying it anyway becfause $AVGO wants this company for whatever reason.$ECA will re-test yearly lows again. Beware of gassy stocks and $CHK.Click Novoadvisor, top right, to check if any of the mentioned stocks are held.Now: what are you trading today? Share your ideas to ~900 members!